ACHIEVEMENT OF PASDAS LOW DISEASE ACTIVITY AND VERY LOW DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL OVER 4 YEARS AND THE OVERLAP WITH DAPSA AND MDA DISEASE ACTIVITY TARGETS

被引：0
|
作者：
Coates, Laura C. [1 ]
Merola, Joseph F. [2 ]
Fitzgerald, Oliver [3 ,4 ]
Kavanaugh, Arthur [5 ]
Gottlieb, Alice B. [6 ]
Tillett, William [7 ]
Bauer, Lars [8 ]
Hoepken, Bengt [8 ]
Nurminen, Tommi [8 ]
Mease, Philip J. [9 ,10 ]
Helliwell, Philip [11 ]
van der Heijde, Desiree [12 ]
机构：
[1] Nuffield Orthopaed Ctr, Oxford, England
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[3] St Vincents Univ Hosp, Dublin, Ireland
[4] Univ Coll Dublin, Conway Inst Biomol Res, Dublin, Ireland
[5] UC San Diego Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA USA
[6] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA
[7] Royal Natl Hosp Rheumat Dis, Bath, Avon, England
[8] UCB Pharma, Monheim, Germany
[9] Swedish Med Ctr, Seattle, WA USA
[10] Univ Washington, Seattle, WA 98195 USA
[11] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[12] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.765
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0742
引用
收藏
页码：1836 / 1837
页数：2
相关论文
共 50 条
  • [41] DISEASE ACTIVITY IN PSORIATIC ARTHRITIS-ESR (DAPSA-ESR) MAY BE A VALID TOOL TO EVALUATE DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS WHEN CRP IS NOT AVAILABLE
    Ale, A. L. Coronel
    Schneeberger, E. E.
    Cerda, O. L.
    Zaffarana, C. A.
    Fornaro, M.
    Landi, M.
    Citera, G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S118 - S118
  • [42] Comprehensive Disease Remission Achieved By Certolizumab Pegol Treatment, and Factors Associated With Certolizumab Pegol Comprehensive Disease Remission, In Rheumatoid Arthritis Patients With Predominantly High Disease Activity
    Tanaka, Yoshiya
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Okamoto, Tadao
    Wada, Yumiko
    Shoji, Toshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S990 - S990
  • [43] Disease Activity and Clinical Response Early in the Course of Treatment Predict Long-Term Outcomes in Psoriatic Arthritis Patients Treated with Certolizumab Pegol
    Mease, Philip
    Fleischmann, Roy
    Davies, Owen
    Nurminen, Tommi
    van der Heijde, Desiree
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S685 - S685
  • [44] DISEASE ACTIVITY AND CLINICAL RESPONSE EARLY IN THE COURSE OF TREATMENT PREDICT LONG-TERM OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL
    Mease, P. J.
    Fleischmann, R.
    Davies, O.
    Nurminen, T.
    van der Heijde, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 741 - 741
  • [45] PSORIATIC ARTHRITIS PATIENTS ACHIEVING DAPSA REMISSION/LOW DISEASE ACTIVITY HAVE BETTER LONG-TERM FUNCTIONAL OUTCOMES
    Vargas Cruz, L.
    Boechat Farani, J.
    Rabello Costa, J.
    Menegat, F.
    Andrade Aguas, J. V.
    Ruschel, B.
    Gasparin, A. A.
    Brenol, C.
    Kohem, C.
    Palominos, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1723 - 1724
  • [46] SECUKINUMAB PROVIDES SUSTAINED REMISSION AND LOW DISEASE ACTIVITY RELATED TO DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS (DAPSA): 2 YEAR RESULTS FROM THE FUTURE 2 STUDY
    Smolen, J. S.
    McInnes, I. B.
    Kvien, T. K.
    Pricop, L.
    Fox, T.
    Rasouliyan, L.
    Jugl, S.
    Gaillez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1323 - 1324
  • [47] Impact of Disease Activity on Physical Activity in Patients With Psoriatic Arthritis
    Hernandez-Hernandez, Maria Vanesa
    Sanchez-Perez, Hiurma
    Luna-Gomez, Cristina
    Ferraz-Amaro, Ivan
    Diaz-Gonzalez, Federico
    ARTHRITIS CARE & RESEARCH, 2021, 73 (12) : 1834 - 1844
  • [48] Influence of Disease Activity in the Physical Activity of Psoriatic Arthritis Patients
    Vanesa Hernandez-Hernandez, M.
    Sanchez-Perez, Hiurma
    Delgado-Frias, Esmeralda
    Ferraz-Amaro, Ivan
    Diaz-Gonzalez, Federico
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [49] Disease activity assessment in patients with psoriatic arthritis
    Kerschbaumer, Andreas
    Smolen, Josef S.
    Aletaha, Daniel
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (03): : 401 - 414
  • [50] EFFECTIVENESS OF IL-17 INHIBITORS REVEALED BY MINIMAL DISEASE ACTIVITY (MDA) ACHIEVEMENT OF PSORIATIC ARTHRITIS PATIENTS
    Kato, M.
    Shimada, H.
    Nakashima, S.
    Mansour, M. Mahmoud Fahmy
    Wakiya, R.
    Miyagi, T.
    Sugihara, K.
    Ushio, Y.
    Kameda, T.
    Dobashi, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1688 - 1688
12345